Clin-e-cal clings onto funding

Clin-e-cal, a UK-based digital health app developer partly spun out of University of Manchester, today received an undisclosed sum from Greater Manchester & Cheshire (GM&C) Life Sciences Fund, a UK government-backed vehicle managed by Catapult Ventures.
Founded in 2015, Clin-e-cal partners pharmaceutical and medical device companies to create mobile apps that improve respiratory health by encouraging patients to improve their inhaler technique and stick to their prescriptions.
Clin-e-cal’s first app, Rafi-Tone, is styled like a video game to help younger children enjoy taking their medication.  The spinout also commercialises intellectual property owned by the Manchester University NHS Foundation Trust.
The funding will help Clin-e-c al enhance its partnerships and R&D as it looks to maximise the value of its approach. Chris Spencer, a partner at Catapult Ventures responsible for digital health, has been appointed chairman of Clin-e-cal’s board of directors.
Clin-e-cal was founded by Tariq Aslam, a consultant ophthalmologist at Manchester Royal Eye Hospital and director of the university’s investigative ophthalmology and vision science course. Aslam’s son had suffered breathing problems and disliked using his inhaler.
Clin-e-cal does not appear to have disclosed funding previously.
Vijay Barathan, partner at GM&C Life Sciences Fund, said: “We are looking forward to working with the team to advance their portfolio of innovative digital health respiratory applications.
“Their first product is a great example of how significant medical issues can be solved through the digitisation of healthcare.”